Cholangiopathy as part of post-COVID syndrome

Sharma, 2021, Liver disease and outcomes among COVID-19 hospitalized patients – a systematic review and meta-analysis, Ann. Hepatol., 21, 100273, 10.1016/j.aohep.2020.10.001 Cha, 2020, Gastrointestinal and hepatic manifestations of COVID-19: a comprehensive review, World J. Gastroenterol., 26, 2323, 10.3748/wjg.v26.i19.2323 Yao, 2020, [A pathological report of three COVID-19 cases by minimal invasive autopsies]., Zhonghua bing li xue za zhi = Chinese, J. Pathol., 49, 411 Zhao, 2020, Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids, Protein Cell, 11, 771, 10.1007/s13238-020-00718-6 Roth, 2021, Post–COVID-19 cholangiopathy: a novel entity, Am. J. Gastroenterol., 116, 1077, 10.14309/ajg.0000000000001154 Kirchner, 2015, Update on sclerosing cholangitis in critically ill patients, Vis. Med., 31, 178, 10.1159/000431031 Bartoli, 2021, Primary biliary cholangitis associated with SARS-CoV-2 infection, J. Hepatol., 74, 1245, 10.1016/j.jhep.2021.02.006 Yang, 2012, Bilirubin levels in patients with systemic lupus erythematosus: increased or decreased?, Rheumatol. Int., 32, 2423, 10.1007/s00296-011-1977-9 Anaya, 2021, Post-COVID syndrome